Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (527)	1/22/2000 6:30:00 PM
From: enervestor	Read Replies (1) \| Respond to of 52153

I certainly agree that biotechs have been incredibly undervalued the past couple of years. That's why I have invested much of my portfolio in them as the risk/reward ratio was so stacked in their favor. I love the new valuations on the stocks I already own, but the risk in new investments has greatly increased. I want to see how these new valuations hold up through the summer doldrums before I really accept them as permanent.